triptonide has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geng, Y; Jin, X; Li, Z; Liu, H; Seshadri, VD; Wu, Q | 1 |
| Chen, J; Cui, X; Cui, Y; Gao, B; Giuliano, AE; Han, B; Hao, J; Zhang, X | 1 |
2 other study(ies) available for triptonide and Disease Models, Animal
| Article | Year |
|---|---|
Triptonide, a Diterpenoid Displayed Anti-Inflammation, Antinociceptive, and Anti-Asthmatic Efficacy in Ovalbumin-Induced Mouse Model.
Topics: Allergens; Analgesics; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Diterpenes; Female; Lung; Male; Mice; Mice, Inbred BALB C; Ovalbumin | 2023 |
Identification of triptonide as a therapeutic agent for triple negative breast cancer treatment.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Discovery; Drug Resistance, Neoplasm; Gene Expression; Gene Knockdown Techniques; Humans; Mice; Molecular Structure; Neoplastic Stem Cells; Snail Family Transcription Factors; Triple Negative Breast Neoplasms; Triterpenes; Xenograft Model Antitumor Assays | 2021 |